Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study

Liver disease related to hepatitis B (HBV) and hepatitis C (HCV) may temper the success of antiretroviral therapy (ART) in China. Limited data exist on their prevalence in HIV‐positive Chinese. A multi‐centre, cross‐sectional study was carried out to determine the prevalence and disease characteristics of HBV and HCV co‐infection in HIV‐positive patients across 12 provinces.

[1]  黄亚明,et al.  Journal of the International AIDS Society , 2017 .

[2]  J. Neuhaus,et al.  Baseline prevalence and predictors of liver fibrosis among HIV‐positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial , 2015, HIV medicine.

[3]  Jing Liu,et al.  HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study. , 2014, The Lancet. Infectious diseases.

[4]  P. Klenerman,et al.  Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[5]  R. Gesuita,et al.  Evaluating Liver Fibrosis by Transient Elastometry in Patients With HIV-HCV Coinfection and Monoinfection , 2014, Hepatitis monthly.

[6]  Jing-xing Wang,et al.  Hepatitis B virus infection in a cohort of HIV infected blood donors and AIDS patients in Sichuan, China , 2014, Journal of Translational Medicine.

[7]  Minhee Kang,et al.  Virologic and Serologic Outcomes of Mono Versus Dual HBV Therapy and Characterization of HIV/HBV Coinfection in a US Cohort , 2014, Journal of acquired immune deficiency syndromes.

[8]  Stephen A. Berry,et al.  Impact of Hepatitis Coinfection on Hospitalization Rates and Causes in a Multicenter Cohort of Persons Living With HIV , 2014, Journal of acquired immune deficiency syndromes.

[9]  J. Jia,et al.  Update on epidemiology of hepatitis B and C in China , 2013, Journal of gastroenterology and hepatology.

[10]  M. Gill,et al.  Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[11]  Xi Chen,et al.  Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in central China , 2013, Archives of Virology.

[12]  L. Liu,et al.  Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China , 2013, HIV medicine.

[13]  John F. Flaherty,et al.  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study , 2013, The Lancet.

[14]  J. Sánchez-Payá,et al.  Low-Level HIV Viremia Is Associated With Microbial Translocation and Inflammation , 2013, Journal of acquired immune deficiency syndromes.

[15]  S. Kulkarni,et al.  Characterization of HIV–HBV coinfection in a multinational HIV-infected cohort , 2013, AIDS.

[16]  Taisheng Li,et al.  Immunological and virological responses to combined antiretroviral therapy in HIV/hepatitis B virus-coinfected patients from a multicenter cohort , 2012 .

[17]  J. Blackard,et al.  Low-level HIV infection of hepatocytes , 2012, Virology Journal.

[18]  Nancy Glass,et al.  Global burden of hepatitis C: considerations for healthcare providers in the United States. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  M. Friedrich-Rust,et al.  Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers , 2012, BMC Gastroenterology.

[20]  C. Thio,et al.  HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. , 2012, The Journal of infectious diseases.

[21]  F. Sanai,et al.  A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[22]  C. Torti,et al.  Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  E. Schiff,et al.  Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B , 2010, Hepatology.

[24]  Benjamin K. Chen,et al.  Human immunodeficiency virus (HIV)‐1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein‐1 expression: Implications for the pathogenesis of HIV/hepatitis C virus–induced liver fibrosis , 2010, Hepatology.

[25]  T. Zhang,et al.  Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients , 2010, Epidemiology and Infection.

[26]  Yu Wang,et al.  Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. , 2009, Vaccine.

[27]  O. Kirk,et al.  Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. , 2006, Archives of internal medicine.

[28]  S. Vermund,et al.  Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China , 2006, AIDS.

[29]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[30]  G. Lüchters,et al.  Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection , 2003, The Lancet.

[31]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[32]  J. Phair,et al.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.

[33]  Chien-Jen Chen,et al.  Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.

[34]  G. Xia,et al.  Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992 , 1996 .

[35]  J. Rodríguez-Orengo,et al.  Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. , 2006, Journal of hepatology.